Case ID: f-appx_695/html/0573-01.html
Source: Caselaw Access Project
Author: {"author": "Per Curiam", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

AIA AMERICA, INC., FKA Alzheimer’s Institute of America, Inc., Plaintiff-Appellant Michael J. Mullan, Ronald E. Sexton, Counterclaim Defendants v. ELI LILLY & COMPANY, Elan Pharmaceuticals, Inc., Defendants-Appellees
    2016-2094
    United States Court of Appeals, Federal Circuit.
    August 10, 2017
    Peter Buckley, Fox Rothschild, LLP, Philadelphia, PA, argued for plaintiff-appellant.
    Deborah E. Fishman, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA, argued for all defendants-appellees. Defendant-ap-pellee Elan Pharmaceuticals, Inc. also represented by Katie Jeannine Lewis Scott.
    Lawrence Scott Burwell, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for defendant-appellee Eli Lilly & Company. Also represented by Charles E. Lipsey; Laura Pollard Masu-rovsicy, Washington, DC; Manisha A. De-sai, Eli Lilly and Company, Indianapolis, IN.
    (Newman, Lourie, and Hughes, Circuit Judges).
   JUDGMENT

Per Curiam

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.